CN114432257A - 一种艾氟洛芬缓释片剂及其制备方法 - Google Patents
一种艾氟洛芬缓释片剂及其制备方法 Download PDFInfo
- Publication number
- CN114432257A CN114432257A CN202210078184.8A CN202210078184A CN114432257A CN 114432257 A CN114432257 A CN 114432257A CN 202210078184 A CN202210078184 A CN 202210078184A CN 114432257 A CN114432257 A CN 114432257A
- Authority
- CN
- China
- Prior art keywords
- release
- lefluprofen
- sustained
- mass ratio
- coating layer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210078184.8A CN114432257B (zh) | 2022-01-24 | 2022-01-24 | 一种艾氟洛芬缓释片剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210078184.8A CN114432257B (zh) | 2022-01-24 | 2022-01-24 | 一种艾氟洛芬缓释片剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114432257A true CN114432257A (zh) | 2022-05-06 |
CN114432257B CN114432257B (zh) | 2023-07-25 |
Family
ID=81370049
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210078184.8A Active CN114432257B (zh) | 2022-01-24 | 2022-01-24 | 一种艾氟洛芬缓释片剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114432257B (zh) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5556638A (en) * | 1991-12-05 | 1996-09-17 | Alfatec Pharma Gmbh | Flurbiprofen-containing immediate-effect medicament and its use |
CN102600108A (zh) * | 2012-01-17 | 2012-07-25 | 广州科的信医药技术有限公司 | 一种氟比洛芬缓释胶囊及其制备方法 |
CN102949383A (zh) * | 2012-11-19 | 2013-03-06 | 北京阜康仁生物制药科技有限公司 | 一种抗炎镇痛的药物组合物 |
CN103142552A (zh) * | 2013-02-22 | 2013-06-12 | 广州科的信医药技术有限公司 | 一种洛伐他汀肠溶缓释微丸胶囊及其制备方法 |
CN104434846A (zh) * | 2014-11-17 | 2015-03-25 | 中国药科大学 | 盐酸二甲双胍肠溶缓释微丸及其制备方法 |
CN113350304A (zh) * | 2021-07-15 | 2021-09-07 | 上海博悦生物科技有限公司 | 一种非甾体抗炎类缓释制剂及其制备方法 |
-
2022
- 2022-01-24 CN CN202210078184.8A patent/CN114432257B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5556638A (en) * | 1991-12-05 | 1996-09-17 | Alfatec Pharma Gmbh | Flurbiprofen-containing immediate-effect medicament and its use |
CN102600108A (zh) * | 2012-01-17 | 2012-07-25 | 广州科的信医药技术有限公司 | 一种氟比洛芬缓释胶囊及其制备方法 |
CN102949383A (zh) * | 2012-11-19 | 2013-03-06 | 北京阜康仁生物制药科技有限公司 | 一种抗炎镇痛的药物组合物 |
CN103142552A (zh) * | 2013-02-22 | 2013-06-12 | 广州科的信医药技术有限公司 | 一种洛伐他汀肠溶缓释微丸胶囊及其制备方法 |
CN104434846A (zh) * | 2014-11-17 | 2015-03-25 | 中国药科大学 | 盐酸二甲双胍肠溶缓释微丸及其制备方法 |
CN113350304A (zh) * | 2021-07-15 | 2021-09-07 | 上海博悦生物科技有限公司 | 一种非甾体抗炎类缓释制剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN114432257B (zh) | 2023-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3631762B2 (ja) | トラマドール複式ユニット製剤 | |
JP5775464B2 (ja) | 非晶質cddo−meを含有する遅延放出性経口投薬組成物 | |
EP2205279B1 (en) | Pharmaceutical combination of aliskiren and valsartan | |
CN108066319B (zh) | 一种枸橼酸托法替布肠溶缓释微丸及其制备方法 | |
CN110934853B (zh) | 一种枸橼酸莫沙必利缓释微丸胶囊及其制备方法 | |
JP2003502359A (ja) | 新規製剤 | |
CN112137990A (zh) | 一种依帕司他缓释制剂及其制备方法 | |
EP1154762B1 (en) | Pharmaceutical capsule compositions containing loratadine and pseudoephedrine | |
TWI747906B (zh) | 達格列淨新晶型及其製備方法和用途 | |
JP7428356B2 (ja) | 高いバイオアベイラビリティを有するソラフェニブの医薬組成物、ソラフェニブ経口固形製剤、及びその使用 | |
CN105769773B (zh) | 洛索洛芬钠缓释微丸 | |
CN114432257B (zh) | 一种艾氟洛芬缓释片剂及其制备方法 | |
JP2020510027A5 (zh) | ||
CN108685870A (zh) | 小檗碱及其可形成盐的肠溶微丸、其制备及应用 | |
KR101990951B1 (ko) | 리바스티그민 함유 서방출 의약조성물 | |
CN112057429B (zh) | 雷西纳德控释药物组合物 | |
CN112190564A (zh) | 复方微丸制剂及其制备方法 | |
EP3622948A1 (en) | Multilayered formulations with dual release rate of one or more active principles | |
CN101642433B (zh) | 一种尼美舒利脂质体固体制剂及其药物组合物的制备方法 | |
CN110575443A (zh) | 一种多索茶碱缓释片及其制备方法 | |
TWI823471B (zh) | 沙庫巴曲纈沙坦鈉緩釋組合物、其製備方法及應用 | |
CN115252574B (zh) | 一种替米沙坦微丸及其制备方法和药物制剂 | |
CN115531350B (zh) | 一种阿齐沙坦胶囊及其制备方法 | |
RU2584653C2 (ru) | Фармацевтическая композиция с пролонгированным высвобождением с антипсихотической активностью и способы её получения | |
CN106668018B (zh) | 一种右兰索拉唑钠的缓释胶囊及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20230626 Address after: Building B24, Science and Technology Complex, No. 5 Xinmofan Road, Gulou District, Nanjing City, Jiangsu Province, 211505 Applicant after: NANJING YINUO MEDICINE TECHNOLOGY Co.,Ltd. Applicant after: Nanjing Oceanwide Pharmaceutical Technology Co.,Ltd. Applicant after: NANJING HEALTHNICE PHARMACEUTICAL TECHNOLOGY CO.,LTD. Applicant after: NANJING HEALTHNICE PHARMACEUTICAL CO.,LTD. Applicant after: Hefei Oceanwide Pharmaceutical Technology Co.,Ltd. Address before: 211505 room 2002, building B4, No. 9, Kechuang Avenue, Zhongshan Science Park, Jiangbei new area, Liuhe District, Nanjing, Jiangsu Province Applicant before: NANJING YINUO MEDICINE TECHNOLOGY Co.,Ltd. Applicant before: NANJING HEALTHNICE PHARMACEUTICAL TECHNOLOGY CO.,LTD. Applicant before: NANJING HEALTHNICE PHARMACEUTICAL CO.,LTD. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant |